[1]
P. Popovic, A. Kalamutova, M. Djokic, A. Cuderman, G. Boltežar, and B. Trotovšek, “Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined with Atezolizumab and Bevacizumab”, Radiol Oncol, vol. 60, no. 1, pp. 40–48, Mar. 2026.